NYSE:AIM
AIM ImmunoTech Inc. Stock News
$0.425
+0.0001 (+0.0235%)
At Close: May 08, 2024
AIM ImmunoTech Inc. (AIM) Q4 2023 Earnings Call Transcript
11:32am, Tuesday, 02'nd Apr 2024
AIM ImmunoTech Inc. (NYSE:AIM ) Q4 2023 Earnings Conference Call April 2, 2024 8:30 AM ET Company Participants Thomas Equels - Chief Executive Officer Dr. Christopher McAleer - Scientific Officer Conf
AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference
08:05am, Thursday, 28'th Mar 2024
OCALA, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that Thomas K.
AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast
09:05am, Tuesday, 26'th Mar 2024
OCALA, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will host a conference call and webcast to di
Aimia, Inc. (AIMFF) Q3 2023 Earnings Call Transcript
02:20pm, Tuesday, 14'th Nov 2023
Aimia, Inc. (OTCPK:AIMFF) Q3 2023 Earnings Conference Call November 14, 2023 8:30 AM ET Company Participants Albert Matousek - IR Phil Mittleman - CEO Michael Lehmann - President Steve Leonard - CFO C
AIM ImmunoTech to Discuss Third Quarter 2023 Financial Results on November 15, 2023 and Host Conference Call and Webcast
08:05am, Thursday, 09'th Nov 2023
OCALA, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), announced today that management will host a conference call and webcast to di
AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care
09:05am, Friday, 22'nd Sep 2023
OCALA, Fla., Sept. 22, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced Chris McAleer, Ph.D., Scientific Officer of AIM will present a
AIM ImmunoTech to Present at the H.C. Wainwright 25th Annual Global Investment Conference
09:05am, Tuesday, 05'th Sep 2023
OCALA, Fla., Sept. 05, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that Thomas K. Equels, Chief Executive Officer of AIM, will p
AIM ImmunoTech to Discuss Second Quarter 2023 Financial Results on August 15, 2023, and Host Conference Call and Webcast
09:05am, Wednesday, 09'th Aug 2023
OCALA, Fla., Aug. 09, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will host a conference call and webcast to disc
AIM ImmunoTech to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
08:45am, Wednesday, 14'th Jun 2023
OCALA, Fla., June 14, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeut
AIM ImmunoTech to Discuss First Quarter 2023 Financial Results on May 16, 2023 and Host Conference Call and Webcast
08:50am, Tuesday, 09'th May 2023
OCALA, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeuti
OCALA, Fla., March 27, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeut
AIM ImmunoTech shares rise on news of pancreatic cancer research partnership with AstraZeneca and Erasmus Medical Center
10:26am, Tuesday, 17'th Jan 2023
AIM ImmunoTech Inc (NYSE:AIM) (AIM) announced that it has entered into an external sponsored collaborative clinical research agreement with AstraZeneca and Erasmus Medical Center in the Netherlands t
5 Penny Stocks To Watch After Big News This Week
09:24am, Tuesday, 17'th Jan 2023
Penny stocks to watch with news that are turning heads in the stock market this week. The post 5 Penny Stocks To Watch After Big News This Week appeared first on Penny Stocks to Buy, Picks, News and I
AIM ImmunoTech broadens patent portfolio with new Netherlands utility patent
09:25am, Monday, 09'th Jan 2023
AIM ImmunoTech Inc (NYSE:AIM) has announced that the Netherlands Patent Office has granted the company a utility patent covering rugged dsRNA, a double-stranded RNA product related to its lead candida
AIM ImmunoTech to Present at the ‘Virtual Investor 2023 Companies to Watch Event'
08:45am, Thursday, 05'th Jan 2023
Live video webcast on Wednesday, January 18th at 11:00 AM ET Live video webcast on Wednesday, January 18th at 11:00 AM ET